FDA Approves New PARP Inhibitor for BRCA-mutant Ovarian Cancer
On Monday, the U.S. Food and Drug Administration (FDA) announced good news for a subgroup of patients with ovarian...
Category: Meetings
On Monday, the U.S. Food and Drug Administration (FDA) announced good news for a subgroup of patients with ovarian...
Attendees gathered firsthand information on all things breast cancer during the five-day San Antonio Breast Cancer Symposium, which showcased...
Results from the phase III clinical trial BELLE-3, presented at the San Antonio Breast Cancer Symposium on Dec. 8,...
Data presented at the San Antonio Breast Cancer Symposium showed that five additional years of the aromatase inhibitor (AI)...
A study presented Thursday, Dec. 8, at the San Antonio Breast Cancer Symposium found that women who received breast...
Later this week, more than 200 researchers will convene in Montreal for a four-day conference on DNA Repair: Tumor...
This month is Breast Cancer Awareness Month, a type of cancer against which we have made much progress. However,...
Liquid biopsies, noninvasive tests performed on biofluids to detect genetic alterations in tumors, are a recent revolution in the...
The American Association for Cancer Research (AACR) will host its first ever Special Conference on Engineering and Physical Sciences...
Cancer immunotherapy refers to treatments that can unleash the power of a patient’s immune system to fight his or...